The 88 rating InvestorsObserver gives to Citius Pharmaceuticals Inc (CTXR) stock puts it near the top of the Healthcare sector.

In addition to scoring higher than 100 percent of stocks in the Healthcare sector, CTXR’s 88 overall rating means the stock scores better than 88 of all stocks.

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds.

The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What’s Happening With Citius Pharmaceuticals Inc Stock Today?

Citius Pharmaceuticals Inc (CTXR) stock has risen 7.31% while the S&P 500 is down -0.27% as of 2:05 PM on Monday, Jun 14. CTXR is up $0.19 from the previous closing price of $2.60 on volume of 5,123,991 shares. Over the past year the S&P 500 is up 38.14% while CTXR is up 217.05%. CTXR lost -$0.38 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Citius Pharmaceuticals Inc (CTXR) Stock.